Lilly Announces Acquisition of Hypnion
Deal shall bolster Lilly's Sleep Disorder Research with promising insomnia compound
Eli Lilly and Company and Hypnion, Inc. announced that they have signed a definitive merger agreement whereby Lilly will acquire Hypnion, a privately held neuroscience drug discovery company focused on sleep disorders. The transaction has received the requisite approval of Hypnion stockholders and is expected to close near the end of the first quarter of 2007, contingent upon clearance under the Hart-Scott-Rodino Anti-Trust Improvements Act and other customary closing conditions. Financial terms of the deal were not disclosed.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Chemical scissors enable structural editing of layered materials - Structural editing strategy of MAX phases and MXenes
New cost-effective instrument measures molecular dynamics on a picosecond timescale
Tiniest imperfections make big impacts in nano-patterned materials

Two tricks for biocatalysis - Plasmas usually have a destructive effect on enzymes - But in this instance, they supply them with a building block for biocatalysis at the push of a button
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo - Company states the realisation of generic competition is neither certain nor imminent
